EPA:ALOPM - Euronext Paris - Matif - FR001400CM63 - Common Stock - Currency: EUR
EPA:ALOPM (3/7/2025, 7:00:00 PM)
0.39
+0.01 (+3.17%)
The current stock price of ALOPM.PA is 0.39 EUR. In the past month the price decreased by -32.53%. In the past year, price decreased by -71%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 21.07 | 346.68B | ||
1ABBV.MI | ABBVIE INC | 20.82 | 342.48B | ||
AMG.DE | AMGEN INC | 16.43 | 161.21B | ||
1AMGN.MI | AMGEN INC | 15.84 | 160.89B | ||
1GILD.MI | GILEAD SCIENCES INC | 25.67 | 135.84B | ||
GIS.DE | GILEAD SCIENCES INC | 25.39 | 134.40B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | 1667.04 | 115.58B | ||
ARGX.BR | ARGENX SE | 253.61 | 33.75B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 24.36B | ||
IDP.DE | BIOGEN INC | 9.25 | 20.54B | ||
1BIIB.MI | BIOGEN INC | 8.39 | 19.21B | ||
0QF.DE | MODERNA INC | N/A | 13.19B |
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 19 full-time employees. The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.
ONCODESIGN PRECISION MEDICIN
18 Rue Jean Mazen
Dijon BOURGOGNE-FRANCHE-COMTE FR
Employees: 19
Company Website: https://www.oncodesign.com/
The current stock price of ALOPM.PA is 0.39 EUR. The price increased by 3.17% in the last trading session.
The exchange symbol of ONCODESIGN PRECISION MEDICIN is ALOPM and it is listed on the Euronext Paris - Matif exchange.
ALOPM.PA stock is listed on the Euronext Paris - Matif exchange.
10 analysts have analysed ALOPM.PA and the average price target is 1.99 EUR. This implies a price increase of 410% is expected in the next year compared to the current price of 0.39. Check the ONCODESIGN PRECISION MEDICIN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) has a market capitalization of 7.09M EUR. This makes ALOPM.PA a Nano Cap stock.
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) currently has 19 employees.
ONCODESIGN PRECISION MEDICIN (ALOPM.PA) has a resistance level at 0.42. Check the full technical report for a detailed analysis of ALOPM.PA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALOPM.PA does not pay a dividend.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 84% to ALOPM.PA. The Buy consensus is the average rating of analysts ratings from 10 analysts.